# Identification of a Potential Therapeutic Target in Neisseria gonorrhoeae Using Pan-Genomics, Subtractive Proteomics and Structure-Based Drug Repurposing

## ğŸ§¬ Background
Neisseria gonorrhoeae is a multidrug-resistant pathogen responsible for gonorrhea and represents a growing global health concern due to increasing antimicrobial resistance. This in-silico study aimed to identify novel therapeutic targets using pan-genomics and subtractive proteomics approaches across 194 genomes. Core genes were screened for essentiality and non-human homology, leading to the identification of 28 potential drug targets. Structural modeling, molecular dynamics simulations, and structure-based virtual screening were performed to identify high-affinity ligands. Two promising lead compounds were identified for further experimental validation.

## ğŸ¯ Objective
To identify novel drug targets and potential small-molecule inhibitors against multidrug-resistant Neisseria gonorrhoeae using in-silico bioinformatics approaches.

## ğŸ› ï¸ Methodology
Pan-genome Analysis â†’ Essential Gene Identification â†’ Non-human Homology Filtering â†’ DrugBank Screening â†’ Structure Prediction â†’ Molecular Dynamics Simulation â†’ Virtual Screening â†’ MM/GBSA Refinement

## ğŸ“Š Key Results
- 1,566 core genes identified
- 28 prioritized novel drug targets
- 4 cytoplasmic proteins
- 7 high-affinity ligands identified
- 2 promising lead compounds

## ğŸ“ˆ Selected Visualizations
<p align="center">
  <img src="images/pangenome_pie.png" width="60%">
</p>
<p align="center">
  <img src="images/pangenome_matrix.png" width="60%">
</p>
<p align="center">
  <img src="images/3d_structure of protein.png" width="60%">
</p>
<p align="center">
  <img src="images/rmsd.png" width="60%">
</p>
